RH
Highly rated in
14
conditions
Highly rated in
14
conditions
Check Dr. Russell K. Hales' experience treating your condition:
About Dr. Russell K. Hales

Russell Hales is a Radiation Oncologist in Baltimore, Maryland. Hales has been practicing medicine for over 18 years and is highly rated in 14 conditions, according to our data. His top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NCSLC), Stent Placement, and Orchiectomy. He is licensed to treat patients in Maryland. Hales is currently accepting new patients.

His clinical research consists of co-authoring 63 peer reviewed articles and participating in 4 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Russell K. Hales it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Russell K. Hales accepts the following insurance:

  •  Ambetter

Call to see if your plan is accepted.
Locations
4940 Eastern Ave, Baltimore, MD 21224
Background & Education
Graduate Institution
Johns Hopkins University School Of Medicine, 2005
Specialties
Radiation Oncology
Licenses
Radiology in MD
Hospital Affiliations
Howard County General Hospital
Johns Hopkins Bayview Medical Center
The Johns Hopkins Hospital
Sibley Memorial Hospital
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


4 Clinical Trials

Preservation of Cognition and Neuropsychiatric Functioning With Corpus Callosum Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases: A Pilot Study
Stereotactic Body Radiation Therapy and Short-Term Androgen Ablation for Intermediate-Risk, Localized, Adenocarcinoma of the Prostate
Phase IB Trial of Induction Nivolumab or Nivolumab/Relatlimab Prior to Concurrent Chemoradiation in Patients With Operable Stage II/III Esophageal/ Gastroesophageal Junction Cancer
View 2 Less Clinical Trial -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors